411 related articles for article (PubMed ID: 25445234)
21. Biomarkers for monitoring chemotherapy-induced cardiotoxicity.
Cao L; Zhu W; Wagar EA; Meng QH
Crit Rev Clin Lab Sci; 2017 Mar; 54(2):87-101. PubMed ID: 28013560
[TBL] [Abstract][Full Text] [Related]
22. Clinical biomarkers of cardiac injury: cardiac troponins and natriuretic peptides.
Apple FS
Toxicol Pathol; 2006; 34(1):91-3. PubMed ID: 16507549
[TBL] [Abstract][Full Text] [Related]
23. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
[TBL] [Abstract][Full Text] [Related]
24. Detection and prevention of cardiac complications of cancer chemotherapy.
Monsuez JJ
Arch Cardiovasc Dis; 2012 Nov; 105(11):593-604. PubMed ID: 23177488
[TBL] [Abstract][Full Text] [Related]
25. Comparison of cardiac troponin I and T, including the evaluation of an ultrasensitive assay, as indicators of doxorubicin-induced cardiotoxicity.
Reagan WJ; York M; Berridge B; Schultze E; Walker D; Pettit S
Toxicol Pathol; 2013; 41(8):1146-58. PubMed ID: 23531791
[TBL] [Abstract][Full Text] [Related]
26. Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide.
Morandi P; Ruffini PA; Benvenuto GM; La Vecchia L; Mezzena G; Raimondi R
Bone Marrow Transplant; 2001 Aug; 28(3):277-82. PubMed ID: 11535996
[TBL] [Abstract][Full Text] [Related]
27. Natriuretic peptides: biochemical markers of anthracycline cardiac toxicity?
Urbanova D; Urban L; Danova K; Simkova I
Oncol Res; 2008; 17(2):51-8. PubMed ID: 18543606
[TBL] [Abstract][Full Text] [Related]
28. Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
Perik PJ; Lub-De Hooge MN; Gietema JA; van der Graaf WT; de Korte MA; Jonkman S; Kosterink JG; van Veldhuisen DJ; Sleijfer DT; Jager PL; de Vries EG
J Clin Oncol; 2006 May; 24(15):2276-82. PubMed ID: 16710024
[TBL] [Abstract][Full Text] [Related]
29. Cardiac biomarkers indicate a need for sensitive cardiac imaging among long-term childhood cancer survivors exposed to anthracyclines.
Ylänen K; Poutanen T; Savukoski T; Eerola A; Vettenranta K
Acta Paediatr; 2015 Mar; 104(3):313-9. PubMed ID: 25393922
[TBL] [Abstract][Full Text] [Related]
30. [Assessment of cardiotoxicity of high dose cyclophosphamide with electrocardiographic, echocardiographic, and troponin I monitoring in patients with breast tumors].
Benvenuto GM; La Vecchia L; Morandi P; Ruffini P; Mezzena G
Ital Heart J Suppl; 2000 Nov; 1(11):1457-63. PubMed ID: 11109196
[TBL] [Abstract][Full Text] [Related]
31. Identifying cancer patients at risk for cardiotoxicity.
Salvatici M; Sandri MT
Future Oncol; 2015; 11(14):2077-91. PubMed ID: 26198838
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of cardiac biomarkers in the prediction of right ventricular dysfunction before echocardiography in acute pulmonary embolism.
Choi HS; Kim KH; Yoon HJ; Hong YJ; Kim JH; Ahn Y; Jeong MH; Cho JG; Park JC; Kang JC
J Cardiol; 2012 Dec; 60(6):508-13. PubMed ID: 22902901
[TBL] [Abstract][Full Text] [Related]
33. The Role of Biomarkers in Cardio-Oncology.
Ananthan K; Lyon AR
J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy.
Cardinale D; Sandri MT; Colombo A; Colombo N; Boeri M; Lamantia G; Civelli M; Peccatori F; Martinelli G; Fiorentini C; Cipolla CM
Circulation; 2004 Jun; 109(22):2749-54. PubMed ID: 15148277
[TBL] [Abstract][Full Text] [Related]
35. Cardiac troponins--biochemical markers of cardiac toxicity after cytostatic therapy.
Urbanová D; Urban L; Carter A; Maasova D; Mladosievicova B
Neoplasma; 2006; 53(3):183-90. PubMed ID: 16652186
[TBL] [Abstract][Full Text] [Related]
36. Myostatin as a Marker for Doxorubicin Induced Cardiac Damage.
Kesik V; Honca T; Gulgun M; Uysal B; Kurt YG; Cayci T; Babacan O; Gocgeldi E; Korkmazer N
Ann Clin Lab Sci; 2016; 46(1):26-31. PubMed ID: 26927339
[TBL] [Abstract][Full Text] [Related]
37. New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide.
van Boxtel W; Bulten BF; Mavinkurve-Groothuis AM; Bellersen L; Mandigers CM; Joosten LA; Kapusta L; de Geus-Oei LF; van Laarhoven HW
Biomarkers; 2015 Mar; 20(2):143-8. PubMed ID: 25980453
[TBL] [Abstract][Full Text] [Related]
38. NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivors.
Zidan A; Sherief LM; El-sheikh A; Saleh SH; Shahbah DA; Kamal NM; Sherbiny HS; Ahmad H
Dis Markers; 2015; 2015():513219. PubMed ID: 25960594
[TBL] [Abstract][Full Text] [Related]
39. Alternative Biomarkers for Combined Biology.
Kim YH; Kirsop J; Tang WH
Heart Fail Clin; 2017 Apr; 13(2):381-401. PubMed ID: 28279423
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children.
Sherief LM; Kamal AG; Khalek EA; Kamal NM; Soliman AA; Esh AM
Hematology; 2012 May; 17(3):151-6. PubMed ID: 22664114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
